Visually mapping avian flu may help H1N1
UPI - Tue Nov 17, 3:48 pm ETCOLUMBUS, Ohio, Nov. 17 (UPI) -- U.S. researchers linked several powerful computer systems to analyze enormous amounts of genetic data on the H5N1 virus, also known as avian flu.
140 Stories, most recent news story added Wed Nov 18, 10:09 am ET
COLUMBUS, Ohio, Nov. 17 (UPI) -- U.S. researchers linked several powerful computer systems to analyze enormous amounts of genetic data on the H5N1 virus, also known as avian flu.
BEIJING, Nov. 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S.
In case you didn't tune into The Washington Times' nationally syndicated radio show, "America's Morning News" - heard in Washington on WTNT-AM 570 and coast-to-coast via the Talk Radio Network - here's what four of Tuesday's guests told co-hosts Melanie Morgan and John McCaslin: - Former Attorney General Michael B. Mukasey: Mr. Mukasey, a retired chief federal judge in New York, blasted his ...
Asia will receive a stockpile of 500,000 courses of H1N1 flu drugs by April next year to supplement any shortfall in the region, an official with a Japanese donor agency said on Tuesday.
CEL-SCI Corporation , a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today the start of the Company's first clinical study for hospitalized H1N1 patients at The Johns Hopkins University School of Medicine .
Medicago Inc. , a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles , today announced that Frederic Ors, VP Business Development will be presenting at the Influenza Congress USA 2009 on November 20, 2009 at 11:00 am at The Westin Washington, Washington, D.C.
AUSTIN, Texas----Asuragen, Inc. announced today that it has entered into an exclusive agreement with Life Technologies Corporation to develop and distribute worldwide an in-vitro diagnostic test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia .
Nov. 17 (Bloomberg) -- China and the World Health Organization agreed to open an influenza research center in Beijing to identify and share knowledge about new strains.
Testimony of Alex Garza, MD, MPH, Assistant Secretary for Health Affairs and Chief Medical Officer, Office of Health Affairs, before the Senate Homeland Security and Governmental Affairs Committee on "H1N1 Flu: Getting the Vaccine to Where it is Most Needed"
Sinovac Biotech Ltd. , a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company's H1N1 vaccine.
DUBLIN----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009" to their offering.
Flight Paths of Death
When word spread in 2005 that cats could catch avian flu, pet owners needlessly panicked.
BEIJING, Nov. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today that it was selected by the Shanghai Government to supply its inactivated hepatitis A vaccine, Healive, to the public market of Shanghai.
BEIJING, Nov. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
WEST HAVEN, Conn.----NanoViricides, Inc. , announced today that the Company’s President, Anil R. Diwan, PhD, has been invited to give a talk at the Nano and Green Tech 2009 Conference on November 18, 2009 .